Paradigmatic shifts in the management of breast cancer

Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944).

Breast cancer research and treatment·2008

Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2005

Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2003

Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and Leukemia Group B Study 8662.

Clinical cancer research : an official journal of the American Association for Cancer Research·2001

HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000

Purchasing oncology services. Kerr L. White Institute/American Cancer Society Task Force on Purchasing Oncology Services.

Cancer·2000

Advances in Systemic Treatment of Breast Cancer.

The New England journal of medicine·2026

Optogenetic Therapy for Restoring Aspects of Visual Function.

The New England journal of medicine·2026

Optimizing management strategies for T4b esophageal cancer: the role of TEVAR in multimodal treatment approaches.

Scandinavian journal of gastroenterology·2026

Prophylaxis Durations and Risks of Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients: An International, Multicenter Cohort Study.

Transplant infectious disease : an official journal of the Transplantation Society·2026

Australian Practical Guide on the Management of Muscle-Invasive Bladder Cancer.

Asia-Pacific journal of clinical oncology·2026

[Efficacy of bidirectional switching therapy between adrenal ablation and adrenalectomy in patients with primary aldosteronism].

Zhonghua yi xue za zhi·2026

[Analysis of efficacy and prognostic factors of neoadjuvant chemoradiotherapy in locally advanced mid-low rectal cancer patients with RAS gene mutation].

Zhonghua yi xue za zhi·2026

[Expert consensus on co-ablation therapy for the perioperative management of bone and soft tissue tumors].

Zhonghua nei ke za zhi·2026

Related Experiment Videos

Paradigmatic shifts in the management of breast cancer

Related Concept Videos

Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944).

Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13.

Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.

Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and Leukemia Group B Study 8662.

HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer.

Purchasing oncology services. Kerr L. White Institute/American Cancer Society Task Force on Purchasing Oncology Services.

Advances in Systemic Treatment of Breast Cancer.

Optogenetic Therapy for Restoring Aspects of Visual Function.

Optimizing management strategies for T4b esophageal cancer: the role of TEVAR in multimodal treatment approaches.

Prophylaxis Durations and Risks of Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients: An International, Multicenter Cohort Study.

Australian Practical Guide on the Management of Muscle-Invasive Bladder Cancer.

[Efficacy of bidirectional switching therapy between adrenal ablation and adrenalectomy in patients with primary aldosteronism].

[Analysis of efficacy and prognostic factors of neoadjuvant chemoradiotherapy in locally advanced mid-low rectal cancer patients with RAS gene mutation].

[Expert consensus on co-ablation therapy for the perioperative management of bone and soft tissue tumors].

Related Experiment Videos

Paradigmatic shifts in the management of breast cancer

Related Concept Videos

Related Articles